Citations

Showing 10 of 108094 citations.

Single-site ventricular pacing via the coronary sinus in patients with tricuspid valve disease
Noheria, Amit , Zyl, Martin van , Scott, Luis R. , Madhavan, Malini , Asirvatham, Samuel J. , Van Zyl, Martin, Asirvatham, Samuel J , Srivathsan, Komandoor , McLeod, Christopher J.

Mayo Clinic

EP Europace | January 24, 2018 | Volume: 20 | Issue: 4 | Pages: 636-642

10.1093/europace/euw422 | PMID 28339945 Get It

Brief Report: Cancer Immunotherapy in Patients With Preexisting Rheumatic Disease: The Mayo Clinic Experience
Richter, Michael , Pinkston, Olga, Kottschade, Lisa A. , Finnes, Heidi D. , Thanarajasingam, Uma , Richter, Michael D , Markovic, Svetomir N.

Mayo Clinic

Arthritis & Rheumatology | January 24, 2018 | Volume: 70 | Issue: 3 | Pages: 356-360

10.1002/art.40397 | PMID 29363290 Get It

ObjectiveTo determine the risk of rheumatic disease flare and adverse effects in patients with preexisting rheumatic disease who were receiving immune checkpoint inhibitor (ICI) therapy.MethodsA retrospective medical record review was performed to identify all patients who received ICI therapy at Mayo Clinic in Rochester, Minnesota between 2011 and 2016 (~700 patients). Those with a preexisting rheumatic disease were identified using specific diagnostic codes.ResultsSixteen patients were identified (81% female, median age 68.5 years). The most common rheumatic diseases were rheumatoid arthritis (n = 5), polymyalgia rheumatica (n = 5), Sjögren's syndrome (n = 2), and systemic lupus erythematosus (n = 2). Seven patients were receiving immunosuppressive therapy or glucocorticoids for their rheumatic disease at the time of initiation of the ICI. The primary malignancies were melanoma (n = 10), pulmonary (n = 4), or hematologic (n = 2). In most cases, ICIs were offered only after failure of several other therapies. Immune‐related adverse effects (IRAEs) occurred in 6 patients, and all were treated successfully with glucocorticoids and discontinuation of the ICI therapy. There were no significant differences in time from cancer diagnosis to immunotherapy, duration of immunotherapy, age, or sex between the patients with and those without IRAEs.ConclusionTo our knowledge, this represents the largest single‐center cohort of patients with rheumatic diseases who were exposed to modern cancer immunotherapy. Only a minority of these patients experienced a flare of their preexisting rheumatic disease or any other IRAE.
Cranial neuropathy and severe pain due to early disseminated Borrelia burgdorferi infection
Sohail, Muhammad Rizwan , Sohail, M. Rizwan , Ebner, Derek, DeSimone, Daniel, Sohail, Muhammad Rizwan , Sohail, M Rizwan , Ebner, Derek W. , Smith, Kelsey M. , DeSimone, Daniel C.

Mayo Clinic

BMJ Case Reports | January 23, 2018 | Volume: 2018 | Issue: No issue available | Pages: bcr-2017-223307

10.1136/bcr-2017-223307 | PMID 29367377 Get It

A 61-year-old man presented to the emergency department in the summer with a right seventh cranial nerve lower motor neuron palsy and worsening paraesthesias for 6 weeks. He had debilitating pain at the scalp and spine. Prior work up was unrevealing. The patient resided in the upper Midwest region of the USA and worked outdoors, optimising the landscape for white tailed deer. Repeat cerebrospinal fluid testing revealed a lymphocytic pleocytosis and positive IgM Lyme serology. Brain MRI demonstrated enhancement of multiple cranial nerves bilaterally. He was diagnosed with early Lyme neuroborreliosis and treated with 28 days of intravenous ceftriaxone. While the painful meningoradiculitis, also known as Bannwarth syndrome, is more commonly seen in Europe, facial palsy is more frequently encountered in the USA. Clinical manifestations of neuroborreliosis are important to recognise as the classic presentation varies by geography and on occasion repeat serological testing may be necessary.
Comparative Assessment of Patient Preferences and Tolerability in Barrett Esophagus Screening
Blevins, Christopher H. , Egginton, Jason S. , Shah, Nilay D., Johnson, Michele L., Iyer, Prasad G.

Mayo Clinic

Journal of Clinical Gastroenterology | January 23, 2018 | Volume: 52 | Issue: 10 | Pages: 880-884

10.1097/mcg.0000000000000991 | PMID 29369237 Get It

Goals: To determine patient preference for the Barrett esophagus (BE) screening techniques. Background: Sedated esophagogastroduodenoscopy (sEGD) and unsedated transnasal endoscopy (uTNE) are both potential techniques for BE screening. However, systematic assessment of patient preference for these 2 techniques is lacking. As part of a comparative effectiveness randomized trial of BE screening modalities, we measured short-term patient preferences for the following approaches: in-clinic uTNE (huTNE), mobile-based uTNE (muTNE), and sEGD using a novel assessment instrument. Study: Consenting community patients without known BE were randomly assigned to receive huTNE, muTNE, or sEGD, followed by a telephone administered preference and tolerability assessment instrument 24 hours after study procedures. Patient preference was measured by the waiting trade-off method. Results: In total, 201 patients completed screening with huTNE (n=71), muTNE (n=71), or sEGD (n=59), and a telephone interview. Patients’ preferences for sEGD and uTNE using the waiting trade-off method were comparable (P=0.51). Although tolerability scores were superior for sEGD (P<0.001) compared with uTNE, scores for uTNE examinations were acceptable. Conclusions: Patient preference is comparable between sEGD and uTNE for diagnostic examinations conducted in an endoscopy suite or in a mobile setting. Given acceptable tolerability, uTNE may be a viable alternative to sEGD for BE screening.
Association Between Left Atrial Appendage Occlusion and Readmission for Thromboembolism Among Patients With Atrial Fibrillation Undergoing Concomitant Cardiac Surgery
Piccini, Jonathan P. , Wang, Tongrong, Malaisrie, S. Chris, Holmes, David R. , Suri, Rakesh M. , Mack, Michael J. , Badhwar, Vinay , Gaca, Jeffrey G., Chow, Shein‐Chung, Brennan, James M. , Malaisrie, S. Chris , Friedman, Daniel J , Zheng, Jiayin , Jacobs, Jeffrey P. , Peterson, Eric D.

Mayo Clinic

JAMA | January 23, 2018 | Volume: 319 | Issue: 4 | Pages: 365

10.1001/jama.2017.20125 | PMID 29362794 Get It

Mycobacterium abscessusinfections in lung transplant recipients: 15‐year experience from a single institution
Osmani, Morsal, Álvarez, Salvador, Odell, John A., Thomas, Mathew , Sotello, David , Thomas, Mathew

Mayo Clinic

Transplant Infectious Disease | January 23, 2018 | Volume: 20 | Issue: 2 | Pages: No page available

10.1111/tid.12835 | PMID 29359872 Get It

AbstractPurposeTo evaluate our institutional experience withMycobacterium abscessusinfections occurring in lung transplant recipients (LTR).MethodsWe retrospectively reviewed our prospectively collected institutional adult lung transplant database from 2001 to 2015 to identify patients withM. abscessusorMycobacterium chelonae/abscessusinfection before or after transplantation. Untreated, colonized patients were excluded from the study. Electronic health records of nine out of 516 lung recipients (1.74%) with clinical infection were reviewed to determine outcomes.ResultsSeven patients acquired the infection after transplantation. Indications for transplantation were: idiopathic pulmonary fibrosis (in 6), chronic obstructive pulmonary disease (in 2), and cystic fibrosis (in 1). Five patients (55.5%) underwent bilateral lung transplantation; one patient required bilateral re‐transplantation for complications from infection.M. abscessuswas isolated from the respiratory tract with a median time of 7.5 months (range: 3 days to 13 months) from transplantation. All patients were treated using a multidrug regimen, with durations ranging from 3 days to 12 months. Complications from infection included death in one patient, bronchial anastomotic dehiscence in one patient, delayed bronchial occlusions in two patients, and osteomyelitis of the knee in one patient. Median survival time from transplantation was 39 months (range: 11‐96 months) and from the date of first positive culture was 58 months (range: 3‐91 months). Five patients (55.5%) were cured but two had re‐infections >1 year later.ConclusionsMycobacterium abscessusinfection inLTRis rare and can lead to severe complications. Eradication is difficult and usually requires prolonged combination antibiotic therapy and occasionally surgical management.
Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities
Ailawadhi, Sikander , Frank, Ryan D. , Sharma, Mayank , Menghani, Richa, Temkit, M’hamed , Paulus, Shumail M., Khera, Nandita , Hashmi, Shahrukh K. , Advani, Pooja , Swaika, Abhisek, Paulus, Aneel , Aslam, Nabeel , Sher, Taimur , Colón‐Otero, Gerardo , Chanan‐Khan, Asher , Paulus, Shumail, Hashmi, Shahrukh, Chanan-Khan, Asher, Ailawadhi, Sikander , Paulus, Aneel , Roy, Vivek

Mayo Clinic

Cancer | January 23, 2018 | Volume: 124 | Issue: 8 | Pages: 1710-1721

10.1002/cncr.31237 | PMID 29360160 Get It

BACKGROUNDOutcomes have improved significantly in multiple myeloma (MM), but racial disparities in health care access and survival exist. A comprehensive analysis exploring MM care and racial disparities is warranted.METHODSPatients with MM from 1991 to 2010 in the Surveillance, Epidemiology, and End Results‐Medicare database were evaluated for racial trends in clinical myeloma‐defining events (MDEs), the receipt of treatment (drugs and stem cell transplantation; [SCT]), the cost of care, and overall survival (OS).RESULTSAmong 35,842 patients, the frequency of all MDEs at diagnosis increased over time; whereas, in recent years (2006‐2010), all MDEs with the exception of renal dialysis decreased. Blacks had highest rates for all MDEs except bone fractures, which were highest in whites. Over time, the proportion of patients who received any treatment, multiple agents, and SCT increased significantly, and the largest increase was observed in the receipt of immunomodulatory drugs and steroids. There was greater receipt of bortezomib and SCT among whites and blacks and higher receipt of immunomodulatory drugs among Hispanics and Asians (P < .001). Medicare claims were highest during first 6 months after MM diagnosis for blacks and at any time after MM diagnosis for Hispanics. Over time, Medicare claims increased most steadily for Hispanics (P < .001). Hypercalcemia, renal dysfunction, and bone fractures were associated with inferior OS. Blacks and Asians had superior OS compared with whites, but racial differences in OS became less pronounced during 2006 through 2010 (P = .182) compared with prior years (P < .01). Better OS was noted among patients who had higher median incomes.CONCLUSIONSThe current results indicate that there have been significant changes in the management of patients with MM over time and provide an in‐depth understanding of the factors that may help explain racial disparities. Cancer 2018;124:1710‐21. © 2018 American Cancer Society
Three‐dimensional prototyping for procedural simulation of transcatheter mitral valve replacement in patients with mitral annular calcification
Sabbagh, Abdallah El , Eleid, Mackram F. , Matsumoto, Jane M., Anavekar, Nandan S., Al‐Hijji, Mohammed , Said, Sameh M. , Holmes, David R. , Rihal, Charanjit S. , Foley, Thomas A. , El Sabbagh, Abdallah , Al-Hijji, Mohammed A , Nkomo, Vuyisile T. , Rihal, Charanjit S.

Mayo Clinic

Catheterization and Cardiovascular Interventions | January 23, 2018 | Volume: 92 | Issue: 7 | Pages: No page available

10.1002/ccd.27488 | PMID 29359388 Get It

AbstractIntroductionThree‐dimensional (3D) prototyping is a novel technology which can be used to plan and guide complex procedures such as transcatheter mitral valve replacement (TMVR).MethodsEight patients with severe mitral annular calcification (MAC) underwent TMVR. 3D digital models with digital balloon expandable valves were created from pre‐procedure CT scans using dedicated software. Five models were printed. These models were used to assess prosthesis sizing, anchoring, expansion, paravalvular gaps, left ventricular outflow tract (LVOT) obstruction, and other potential procedure pitfalls. Results of 3D prototyping were then compared to post procedural imaging to determine how closely the achieved procedural result mirrored the 3D modeled result.Results3D prototyping simulated LVOT obstruction in one patient who developed it and in another patient who underwent alcohol septal ablation prior to TMVR. Valve sizing correlated with actual placed valve size in six out of the eight patients and more than mild paravalvular leak (PVL) was simulated in two of the three patients who had it. Patients who had mismatch between their modeled valve size and post‐procedural imaging were the ones that had anterior leaflet resection which could have altered valve sizing and PVL simulation. 3D printed model of one of the latter patients allowed modification of anterior leaflet to simulate surgical resection and was able to estimate the size and location of the PVL after inserting a valve stent into the physical model.Conclusion3D prototyping in TMVR for severe MAC is feasible for simulating valve sizing, apposition, expansion, PVL, and LVOT obstruction.
Utility of Pathology Imagebase for standardisation of prostate cancer grading
Egevad, Lars , Delahunt, Brett , Bostwick, David G., Cheville, John C. , Evans, Andrew , Fine, Samson W. , Grignon, David J. , Humphrey, Peter A. , Hörnblad, Jonas, Iczkowski, Kenneth A. , Kench, James G. , Leite, Kátia Ramos Moreira , McKenney, Jesse K. , Pan, Chin‐Chen , Samaratunga, Hemamali , Srigley, John R., Takahashi, Hiroyuki , True, Lawrence D. , Tsuzuki, Toyonori , Varma, Murali , Zhou, Ming , Clements, Mark , McKenney, Jesse K , Pan, Chin-Chen , Tsuzuki, Toyonori , Samaratunga, Hemamali , Berney, Daniel M. , Compérat, Éva , Kristiansen, Glen , Magi‐Galluzzi, Cristina , OXLEY, JON D. , Kwast, Theodorus van der

Mayo Clinic

Histopathology | January 23, 2018 | Volume: 73 | Issue: 1 | Pages: 8-18

10.1111/his.13471 | PMID 29359484 Get It

AimsDespite efforts to standardise grading of prostate cancer, even among experts there is still a considerable variation in grading practices. In this study we describe the use of Pathology Imagebase, a novel reference image library, for setting an international standard in prostate cancer grading.Methods and resultsThe International Society of Urological Pathology (ISUP) recently launched a reference image database supervised by experts. A panel of 24 international experts in prostate pathology reviewed independently microphotographs of 90 cases of prostate needle biopsies with cancer. A linear weighted kappa of 0.67 (95% confidence interval = 0.62–0.72) and consensus was reached in 50 cases. The interobserver weighted kappa varied from 0.48 to 0.89. The highest level of agreement was seen for Gleason score (GS) 3 + 3 = 6 (ISUP grade 1), while higher grades and particularly GS 4 + 3 = 7 (ISUP grade 3) showed considerable disagreement. Once a two‐thirds majority was reached, images were moved automatically into a public database available for all ISUP members at www.isupweb.org. Non‐members are able to access a limited number of cases.ConclusionsIt is anticipated that the database will assist pathologists to calibrate their grading and, hence, decrease interobserver variability. It will also help to identify instances where definitions of grades need to be clarified.
Niche point-of-care endocrine testing – Reviews of intraoperative parathyroid hormone and cortisol monitoring
Chen, Li-Sheng, Singh, Ravinder

Mayo Clinic

Critical Reviews in Clinical Laboratory Sciences | January 23, 2018 | Volume: 55 | Issue: 2 | Pages: 115-128

10.1080/10408363.2018.1425975 | PMID 29357735 Get It